[MOL] Prostate Abstracts... [00723] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Prostate Abstracts...







>
> WEI JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG.
> Development and validation of the expanded prostate cancer index composite
(EPIC) for comprehensive assessment of health-related
> quality of life in men with prostate cancer.
> Urology 2000;56:899-905.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A11113727&aid=B120240&dopt=r&s=prc
>
> SODEE DB, Malguria N, Faulhaber P, Resnick MI, Albert J, Bakale G.
> Multicenter ProstaScint imaging findings in 2154 patients with prostate
cancer(1).
> Urology 2000;56:988-93.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A11113745&aid=B120240&dopt=r&s=prc
>
> BABAIAN RJ, Fritsche H, Ayala A, et al.
> Performance of a neural network in detecting prostate cancer in the
prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL.
> Urology 2000;56:1000-6.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A11113747&aid=B120240&dopt=r&s=prc
>
> MARIANI AJ, Glover M, Arita S.
> MEDICAL VERSUS SURGICAL ANDROGEN SUPRESSION THERAPY FOR PROSTATE CANCER: A
10-YEAR LONGITUDINAL COST STUDY.
> J Urol 2001;165:104-107.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A11115986&aid=B120240&dopt=r&s=prc
>
> RUBIN MA, Mucci NR, Manley S, et al.
> PREDICTORS OF GLEASON PATTERN 4/5 PROSTATE CANCER ON PROSTATECTOMY
SPECIMENS: CAN HIGH GRADE TUMOR BE PREDICTED PREOPERATIVELY?
> J Urol 2001;165:114-118.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A11115989&aid=B120240&dopt=r&s=prc
>
> D'AMICO AV, Wu Y, Chen MH, Nash M, Renshaw AA, Richie JP.
> PERINEURAL INVASION AS A PREDICTOR OF BIOCHEMICAL OUTCOME FOLLOWING
RADICAL PROSTATECTOMY FOR SELECT MEN WITH CLINICALLY LOCALIZED
> PROSTATE CANCER.
> J Urol 2001;165:126-129.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A11115991&aid=B120240&dopt=r&s=prc
>
> VAN BRUSSEL JP, Jan Van Steenbrugge G, Van Krimpen C, et al.
> EXPRESSION OF MULTIDRUG RESISTANCE RELATED PROTEINS AND PROLIFERATIVE
ACTIVITY IS INCREASED IN ADVANCED CLINICAL PROSTATE CANCER.
> J Urol 2001;165:130-135.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A11115992&aid=B120240&dopt=r&s=prc
>
> HEIDENREICH A, Hofmann R, Engelmann UH.
> THE USE OF BISPHOSPHONATE FOR THE PALLIATIVE TREATMENT OF PAINFUL BONE
METASTASIS DUE TO HORMONE REFRACTORY PROSTATE CANCER.
> J Urol 2001;165:136-140.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A11115993&aid=B120240&dopt=r&s=prc
>
> DAVIS JW, Schellhammer PF.
> PROSTATORECTAL FISTULA 14 YEARS FOLLOWING BRACHYTHERAPY FOR PROSTATE
CANCER.
> J Urol 2001;165:189.
>
>
> PLATZ EA, Rimm EB, Willett WC, Kantoff PW, Giovannucci E.
> Racial Variation in Prostate Cancer Incidence and in Hormonal System
Markers Among Male Health Professionals.
> J Natl Cancer Inst 2000;92:2009-2017.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A11121463&aid=B120240&dopt=r&s=prc
>
> HELZLSOUER KJ, Huang HY, Alberg AJ, et al.
> Association Between alpha-Tocopherol, gamma-Tocopherol, Selenium, and
Subsequent Prostate Cancer.
> J Natl Cancer Inst 2000;92:2018-2023.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A11121464&aid=B120240&dopt=r&s=prc


------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------